Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G81971FM
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
Taxonomic Hierarchy
KEGG BRITE Database
- KEGG ID
Pathway
| Pathway Name | Organism |
|---|---|
| Lewis blood group biosynthesis | Bos taurus |
| Lewis blood group biosynthesis | Sus scrofa |
| Lewis blood group biosynthesis | Caenorhabditis elegans |
| Lewis blood group biosynthesis | Homo sapiens |
| Lewis blood group biosynthesis | Dictyostelium discoideum |
| Lewis blood group biosynthesis | Drosophila melanogaster |
| Lewis blood group biosynthesis | Canis familiaris |
| Lewis blood group biosynthesis | Xenopus tropicalis |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dglc-HEX-1:5 2s:n-acetyl 3b:b-dgal-HEX-1:5 4b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 5s:n-acetyl 6b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3o(3+2)4d 4:4d(5+1)5n 5:1o(4+1)6d
- WURCS
- WURCS=2.0/4,4,3/[a2122h-1x_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O][a1221m-1a_1-5]/1-2-3-4/a3-b1_a4-d1_b3-c2
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 7531333 | Effectiveness of multivariate analysis of tumor markers in diagnosis of pancreatic carcinoma: a prospective study in multiinstitutions | Kuno N | 1994 Nov |
|
| 7846010 | Serological Pancreatic Tumor Markers and the MUC1 Apomucin | Ho JJ | 1994 Nov |
|
| 7846012 | CA19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience | Satake K | 1994 Nov |
|
| 7846013 | Comparison of Preoperative Serum CA19-9 Levels with Results of Diagnostic Imaging Modalities in Patients Undergoing Laparotomy for Suspected Pancreatic or Gallbladder Disease | Ritts RE | 1994 Nov |
|
| 7848693 | [Is the carbohydrate antigen Ca 19.9 useful in the diagnosis of pancreatic carcinoma?] | Santander C | 1994 Nov |
|
| 7872711 | Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment | Tanaka N | 1994 Nov |
|
| 7757422 | Calculated conformations of sialyl-Le(x)- and sialyl-Le(a)-lactones | Ellervik U | 1994 Nov |
|
| 7846016 | Diagnosis of Pancreatic Cancer and Prediction of Unresectability Using the Tumor-Associated Antigen CA19-9 | Forsmark CE | 1994 Nov |
|
| 7846014 | CA19-9: the Italian experience | Gullo L | 1994 Nov |
|
| 7872725 | Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma | Diez M | 1994 Nov |
|
